Dr. Andrea Small-Howard — Chief Science Officer

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” gap=”25″ equal_height=”yes” css=”.vc_custom_1510113762967{background-color: #e4ebf3 !important;}”][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][vc_empty_space][vc_single_image image=”655″ img_size=”large” alignment=”center” qode_css_animation=””][vc_empty_space height=”12px”][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1510113771206{background-color: #e4ebf3 !important;}”][vc_column width=”1/4″][/vc_column][vc_column width=”1/2″][vc_column_text css=”.vc_custom_1646333909653{padding-right: 10px !important;padding-left: 10px !important;}”]

Dr. Andrea Small-Howard has more than 15 years’ experience studying cannabinoids and the endocannabinoid system, immunology and cancer treatments; as well as executive experience in the biopharmaceutical industry where she supervised research and development, manufacturing and quality control divisions. She took the lead in obtaining regulatory approvals from the U.S. Food & Drug Administration (“US FDA”) and multiple international regulatory agencies, and has recently assisted other state jurisdictions in developing medical plant regulations. Dr. Small-Howard brings to GB Sciences a passion for advancing clinical research on medicinal applications of cannabinoid compounds in plants, clinical experience in conducting cannabinoid research, strategic vision for creating a vertically-integrated biopharmaceutical pipeline and a track record of successes in the management of biopharmaceutical companies.


Dr. Small-Howard originally received her AB from Occidental College (Magna Cum Laude, Phi Beta Kappa), in addition to receiving both an MBA (Beta Gamma Sigma) and a PhD (USC All-University Merit Fellow) in biological sciences from the University of Southern California. As a post-doctoral fellow at the Queens Medical Center in Honolulu, Hawaii, Dr. Small-Howard led a project group dedicated to the study of cannabinoids in the immune system and published peer-reviewed papers on the subject. At the John A. Bums School of Medicine – University of Hawaii, she led a productive research team as a Research Assistant Professor. Dr. Small-Howard has held management positions at AMDL, Inc. (a small public biotech company), where she took the lead in every stage of product development from discovery through commercialization. As VP of Scientific Oversight at Radient Pharmaceuticals Corp. (RPC), she provided strategic product development and regulatory oversight across multiple international business divisions. At RPC, she also played an active role in creating collaborative research agreements with development partners and research institutions, and she contributed to critical licensing and distribution agreements. In 2011, Dr. Small-Howard founded International Biotechnology Solutions to provide management consulting and has successfully completed projects within the areas of business development, corporate alliance building, product commercialization, corporate restructuring and management of successful fundraising campaigns. For four years, she also served on the Board of Directors for the Center for Healthcare Innovation, a nonprofit, non-partisan and independent organization based in Chicago that is committed to serving as a catalyst for stimulating ideas, people, companies and institutions to collaborate and achieve excellence in healthcare innovation.

[/vc_column_text][vc_empty_space height=”50px”][/vc_column][vc_column width=”1/4″][/vc_column][/vc_row]